Home › Funds › Boxer Capital Management, LLC › ALLO
Boxer Capital Management, LLC position in ALLO
ALLOGENE THERAPEUTICS INC · Health Care
Boxer Capital Management, LLC reported holding 1,500,000 shares of ALLO (ALLOGENE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$3.1M, representing 0.23% of its reported portfolio and ranking #49 among its reported holdings. Boxer Capital Management, LLC has disclosed ALLO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Boxer Capital Management, LLC's ALLO position evolved
Boxer Capital Management, LLC first disclosed a stake in ALLO in Q1 2026 at 2,725,000 shares (US$6.6M). Across 2 filings, Boxer Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,500,000 shares valued at US$3.1M — a reduction of -1,225,000 shares quarter over quarter.. Notable position changes include a 45% trim in Q2 2026 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.73M | $6.65M | New |
| Q2 2026 | 1.50M | $3.12M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALLO and 13F data
ALLO (ALLOGENE THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ALLO — the largest reported positions include PFIZER INC (US$46.9M), Frazier Life Sciences Management, L.P. (US$46.7M), TPG GP A, LLC (US$38.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALLO
- PFIZER INC 22.03M sh · $46.93M · Q2 2026
- Frazier Life Sciences Management, L.P. 22.45M sh · $46.69M · Q2 2026
- TPG GP A, LLC 18.72M sh · $38.93M · Q2 2026
- Sio Capital Management, LLC 13.32M sh · $27.71M · Q2 2026
- GordonMD Global Investments LP 5.30M sh · $11.02M · Q2 2026
- Patient Square Capital LP 5.05M sh · $10.50M · Q2 2026
- Wildcat Capital Management, LLC 2.92M sh · $6.08M · Q2 2026
- DAFNA Capital Management LLC 2.00M sh · $4.16M · Q2 2026
More on Boxer Capital Management, LLC
FAQ
How long has Boxer Capital Management, LLC held ALLO?
Boxer Capital Management, LLC has disclosed ALLO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Boxer Capital Management, LLC's current position in ALLO?
As of Q2 2026, Boxer Capital Management, LLC holds 1.50M shares of ALLO (ALLOGENE THERAPEUTICS INC), valued at $3.12M, representing 0.23% of its reported portfolio and ranking #49.
Has Boxer Capital Management, LLC been buying or selling ALLO?
In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC reduced its position in ALLO.
Which other funds hold ALLO?
Other major institutional holders of ALLO include PFIZER INC, Frazier Life Sciences Management, L.P., TPG GP A, LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.